Literature DB >> 25323860

Increased pulmonary vascular expression of Krüppel-like factor 5 and activated survivin in experimental congenital diaphragmatic hernia.

Alejandro D Hofmann1, Toshiaki Takahashi, Johannes W Duess, Jan-Hendrik Gosemann, Prem Puri.   

Abstract

AIM OF THE STUDY: The high morbidity and mortality in congenital diaphragmatic hernia (CDH) is attributed to pulmonary hypoplasia and persistent pulmonary hypertension (PH). PH is characterized by increased pulmonary artery smooth muscle cell (SMC) proliferation, suppressed apoptosis as well as endothelial dysfunction. Krüppel-like factor 5 (KLF5) belongs to a family of transcription factors that has diverse functions during cell differentiation and embryonic development. KLF5 is preferentially expressed in proliferating SMCs but reduced in differentiated cells. KLF5 induces the expression of Survivin, a 16.5 kDa protein overexpressed in almost all malignancies but hardly detected in normal differentiated tissues. Survivin has been shown to inhibit apoptosis, promote cell proliferation, and enhance angiogenesis. Recent studies have implicated activation of KLF5 and Survivin in the pathogenesis of human and experimental PH. We designed this study to investigate the hypothesis that KLF5 and Survivin expression are increased in nitrofen-induced CDH.
METHODS: Pregnant rats were exposed to nitrofen or vehicle on D9. Fetuses were sacrificed on D21 and divided into nitrofen (n = 16) and control group (n = 16). Quantitative real-time PCR, western blotting, and confocal immunofluorescence were performed to determine pulmonary gene expression levels and protein expression of KLF5, Survivin, and phosphorylated Survivin (p-Survivin). MAIN
RESULTS: Confocal microscopy revealed markedly increased pulmonary vascular KLF5 and p-Survivin expression in lungs of nitrofen-exposed fetuses compared to controls. These results were confirmed by western blotting, showing increased pulmonary expression of KLF5 and p-Survivin. Furthermore, the relative pulmonary gene expressions of KLF5 and Survivin were significantly increased in the CDH group compared to controls (p < 0.005 rsp. p < 0.01).
CONCLUSION: This study provides striking evidence of increased gene and protein expression of KLF5 and activated Survivin in the pulmonary vasculature of nitrofen-induced CDH, suggesting that increased expression of KLF5 may activate p-Survivin expression and play an important role in the pathogenesis of PH in nitrofen-induced CDH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323860     DOI: 10.1007/s00383-014-3606-7

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  22 in total

Review 1.  The key role of apoptosis in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Emin Gurbanov; Xiao Shiliang
Journal:  Eur J Cardiothorac Surg       Date:  2006-07-25       Impact factor: 4.191

Review 2.  Congenital diaphragmatic hernia.

Authors:  Richard Keijzer; Prem Puri
Journal:  Semin Pediatr Surg       Date:  2010-08       Impact factor: 2.754

3.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  KLF5 Interacts with p53 in regulating survivin expression in acute lymphoblastic leukemia.

Authors:  Ningxi Zhu; Lubing Gu; Harry W Findley; Ceshi Chen; Jin-Tang Dong; Lily Yang; Muxiang Zhou
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

Review 5.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

Review 6.  Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.

Authors:  Jin-Tang Dong; Ceshi Chen
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

7.  Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling.

Authors:  Takayuki Shindo; Ichiro Manabe; Yasushi Fukushima; Kazuyuki Tobe; Kenichi Aizawa; Saku Miyamoto; Keiko Kawai-Kowase; Nobuo Moriyama; Yasushi Imai; Hayato Kawakami; Hiroaki Nishimatsu; Takashi Ishikawa; Toru Suzuki; Hiroyuki Morita; Koji Maemura; Masataka Sata; Yasunobu Hirata; Masayuki Komukai; Hiroyuki Kagechika; Takashi Kadowaki; Masahiko Kurabayashi; Ryozo Nagai
Journal:  Nat Med       Date:  2002-07-08       Impact factor: 53.440

Review 8.  Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.

Authors:  David Montani; Marie-Camille Chaumais; Laurent Savale; Delphine Natali; Laura C Price; Xavier Jaïs; Marc Humbert; Gérald Simonneau; Olivier Sitbon
Journal:  Adv Ther       Date:  2009-09-19       Impact factor: 3.845

9.  Disruption of the bone morphogenetic protein receptor 2 pathway in nitrofen-induced congenital diaphragmatic hernia.

Authors:  Jan-Hendrik Gosemann; Florian Friedmacher; Naho Fujiwara; Luis A J Alvarez; Nicolae Corcionivoschi; Prem Puri
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2013-06-18

Review 10.  Cardiovascular risk of rosiglitazone: another perspective.

Authors:  Javier C Waksman
Journal:  J Pharm Pharmacol       Date:  2008-12       Impact factor: 3.765

View more
  3 in total

Review 1.  Kruppel-like Pluripotency Factors as Modulators of Cancer Cell Therapeutic Responses.

Authors:  Mark K Farrugia; Daniel B Vanderbilt; Mohamad A Salkeni; J Michael Ruppert
Journal:  Cancer Res       Date:  2016-03-10       Impact factor: 12.701

2.  miR-29a regulates vascular neointimal hyperplasia by targeting YY1.

Authors:  Yu Zhang; Yong Hui Li; Chao Liu; Chan-Juan Nie; Xin-Hua Zhang; Cui-Ying Zheng; Wen Jiang; Wei-Na Yin; Ming-Hui Ren; Yu-Xin Jin; Shu-Feng Liu; Bin Zheng; Jin-Kun Wen
Journal:  Cell Prolif       Date:  2016-12-02       Impact factor: 6.831

Review 3.  Current knowledge of Krüppel-like factor 5 and vascular remodeling: providing insights for therapeutic strategies.

Authors:  Ziyan Xie; Junye Chen; Chenyu Wang; Jiahao Zhang; Yanxiang Wu; Xiaowei Yan
Journal:  J Mol Cell Biol       Date:  2021-05-07       Impact factor: 6.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.